Health Care Quality and Outcomes for Medicare Patients with Guillain-Barré Syndrome
Official title: Health Care Quality and Outcomes among Medicare Patients with Guillain-Barré Syndrome
Funded at University of South Carolina at Columbia · NIH-11453284 · Data updated 2026-11-12
This grant looks at how care is delivered to people with Guillain-Barré Syndrome on Medicare and how care quality affects recovery.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 1, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $237,254 |
| NIH project number | 1R21NS150172-01 |
| Project ID | NIH-11453284 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with Guillain-Barré Syndrome who are enrolled in Traditional Medicare or Medicare Advantage and receive or have received care in the U.S.
✕Less likely to help
Patients not enrolled in Medicare programs or lacking a GBS diagnosis may not directly benefit.
What this research studies
Guillain-Barré Syndrome is a rare, serious nerve condition that can cause weakness and breathing problems. The project uses large Medicare data to see how quickly people are diagnosed, how hospital care varies, and how post‑acute care influences recovery. It links claims data with facility and post‑acute assessments to understand real-world outcomes across traditional Medicare and Medicare Advantage. The aim is to identify gaps in care and potential differences in outcomes based on where and how patients receive treatment.
Why it matters
Potential benefit: If successful, the work could reveal care patterns that improve diagnosis, hospital care, and post‑acute support for people with GBS.
How similar studies have gone: This study builds on prior work using national claims data; it is positioned to provide updated, real-world insights specific to GBS under Medicare.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Wright, David Bradley — University of South Carolina at Columbia
- Study coordinator: Wright, David Bradley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.